Literature DB >> 16136653

Telomeres and human disease: ageing, cancer and beyond.

Maria A Blasco1.   

Abstract

Telomere length and telomerase activity are important factors in the pathobiology of human disease. Age-related diseases and premature ageing syndromes are characterized by short telomeres, which can compromise cell viability, whereas tumour cells can prevent telomere loss by aberrantly upregulating telomerase. Altered functioning of both telomerase and telomere-interacting proteins is present in some human premature ageing syndromes and in cancer, and recent findings indicate that alterations that affect telomeres at the level of chromatin structure might also have a role in human disease. These findings have inspired a number of potential therapeutic strategies that are based on telomerase and telomeres.

Entities:  

Mesh:

Year:  2005        PMID: 16136653     DOI: 10.1038/nrg1656

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  545 in total

1.  Telomerase and retrotransposons: reverse transcriptases that shaped genomes.

Authors:  Marlene Belfort; M Joan Curcio; Neal F Lue
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

2.  Organ aging and susceptibility to cancer may be related to the geometry of the stem cell niche.

Authors:  Krastan B Blagoev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts.

Authors:  R Faraonio; P Salerno; F Passaro; C Sedia; A Iaccio; R Bellelli; T C Nappi; M Comegna; S Romano; G Salvatore; M Santoro; F Cimino
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

4.  Structurally conserved five nucleotide bulge determines the overall topology of the core domain of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Robert D Peterson; Zhonghua Wang; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

5.  The end is nigh.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2010-08       Impact factor: 4.599

6.  Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths.

Authors:  Masayuki Kimura; Rivka C Stone; Steven C Hunt; Joan Skurnick; Xiaobin Lu; Xiaojian Cao; Calvin B Harley; Abraham Aviv
Journal:  Nat Protoc       Date:  2010-09-02       Impact factor: 13.491

7.  The Nobel Prize in physiology or medicine 2009 "for telomere biology" and its relevance to cancer and related diseases.

Authors:  Rosario Perona
Journal:  Clin Transl Oncol       Date:  2010-10       Impact factor: 3.405

8.  Physical activity, sedentary behavior, and leukocyte telomere length in women.

Authors:  Mengmeng Du; Jennifer Prescott; Peter Kraft; Jiali Han; Edward Giovannucci; Susan E Hankinson; Immaculata De Vivo
Journal:  Am J Epidemiol       Date:  2012-02-01       Impact factor: 4.897

9.  Telomere length as a risk factor for hereditary prostate cancer.

Authors:  Lauren M Hurwitz; Christopher M Heaphy; Corinne E Joshu; William B Isaacs; Yuko Konishi; Angelo M De Marzo; Sally D Isaacs; Kathy E Wiley; Elizabeth A Platz; Alan K Meeker
Journal:  Prostate       Date:  2013-11-28       Impact factor: 4.104

10.  Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.

Authors:  Marco Benati; Martina Montagnana; Elisa Danese; Martina Mazzon; Elisa Paviati; Simone Garzon; Antonio Simone Laganà; Jvan Casarin; Silvia Giudici; Ricciarda Raffaelli; Fabio Ghezzi; Massimo Franchi; Giuseppe Lippi
Journal:  Pathol Oncol Res       Date:  2020-05-27       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.